Finance

Lists
CRDL:TSE
Cardiol Therapeutics Inc
1,60 CAD
0,00%
(0,00) 1D
15-окт., 16:00:01 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CRDL...
Open
1,64 CAD
High
1,65 CAD
Low
1,60 CAD
Mkt. cap
190,29 млн
Avg. vol.
288,97 миң
Volume
279,43 миң
52-wk high
3,23 CAD
52-wk low
1,22 CAD
EPS
-0,34 CAD
Beta
0,66
Shares outstanding
116,82 млн
No. of employees
18
Open
1,64 CAD
High
1,65 CAD
Low
1,60 CAD
Mkt. cap
190,29 млн
Avg. vol.
288,97 миң
Volume
279,43 миң
52-wk high
3,23 CAD
52-wk low
1,22 CAD
EPS
-0,34 CAD
Beta
0,66
Shares outstanding
116,82 млн
No. of employees
18
News stories
From web sources and news partners
About Cardiol Therapeutics Inc
CEODavid Elsley
Employees18
Founded2017
HeadquartersОквилл, Онтарио, Канада
SectorPharmaceutical industry
Last report
2026-ж., 12-авг.
Fiscal period
Q2 2026
-0,05 CAD / -0,10 CAD
+48,28%beat
Revenue / Est. (CAD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,79 млн
2,74 млн
4,95 млн
3,20 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,39 млн
5,29 млн
4,76 млн
4,74 млн
Operating expense
10,18 млн
8,03 млн
9,71 млн
7,94 млн
Total operating expenses
10,18 млн
8,03 млн
9,71 млн
7,94 млн
Operating income
-10,18 млн
-8,03 млн
-9,71 млн
-7,94 млн
Other non operating income
-
951,74 миң
-1,53 млн
1,35 млн
EBT including unusual items
-9,96 млн
-7,21 млн
-10,82 млн
-6,08 млн
EBT excluding unusual items
-9,96 млн
-7,21 млн
-10,82 млн
-6,08 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9,96 млн
-7,21 млн
-10,82 млн
-6,08 млн
Net profit margin
-
-
-
-
Earnings per share
-0,12
-0,07
-0,10
-0,05
Interest and investment income
122,26 миң
175,21 миң
200,72 миң
201,33 миң
Interest expense
-
-
-
-
Net interest expenses
122,26 миң
175,21 миң
200,72 миң
201,33 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-10,17 млн
-8,02 млн
-9,70 млн
-7,93 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору